Editorial: suboptimal ultrasound visualisation in patients undergoing surveillance for hepatocellular carcinoma
- PMID: 35245956
- DOI: 10.1111/apt.16810
Editorial: suboptimal ultrasound visualisation in patients undergoing surveillance for hepatocellular carcinoma
Comment on
-
Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study.Aliment Pharmacol Ther. 2022 Mar;55(6):683-690. doi: 10.1111/apt.16779. Epub 2022 Feb 15. Aliment Pharmacol Ther. 2022. PMID: 35170052
References
REFERENCES
-
- Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68:723-750.
-
- Koh JH, Tan DJH, Ong Y, et al. Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients. Hepatobiliary Surg Nutr. 2021;11:78-93.
-
- Wolf E, Rich NE, Marrero JA, Parikh ND, Singal AG. Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta-analysis. Hepatology. 2021;73:713-725.
-
- Tzartzeva K, Obi J, Rich NE, et al. Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis. Gastroenterology. 2018;154:1706-18.e1.
-
- Schoenberger H, Chong N, Fetzer DT, et al. Dynamic changes in ultrasound quality for hepatocellular carcinoma screening in patients with cirrhosis. Clin Gastroenterol Hepatol. 2021.